The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes
- Address correspondence and reprint requests to Jacqueline M. Stephens, George C. Kent Professor, Louisiana State University, Department of Biological Sciences, 202 Life Sciences Bldg., Baton Rouge, LA 70803. E-mail: jsteph1{at}lsu.edu
Abstract
The purpose of this study was to determine whether pyruvate dehydrogenase kinase (PDK)4 was expressed in adipocytes and whether PDK4 expression was hormonally regulated in fat cells. Both Northern blot and Western blot analyses were conducted on samples isolated from 3T3-L1 adipocytes after various treatments with prolactin (PRL), growth hormone (GH), and/or insulin. Transfection of PDK4 promoter reporter constructs was performed. In addition, glucose uptake measurements were conducted. Our studies demonstrate that PRL and porcine GH can induce the expression of PDK4 in 3T3-L1 adipocytes. Our studies also show that insulin pretreatment can attenuate the ability of these hormones to induce PDK4 mRNA expression. In addition, we identified a hormone-responsive region in the murine PDK4 promoter and characterized a STAT5 binding site in this region that mediates the PRL (sheep) and GH (porcine) induction in PDK4 expression in 3T3-L1 adipocytes. PDK4 is a STAT5A target gene. PRL is a potent inducer of PDK4 protein levels, results in an inhibition of insulin-stimulated glucose transport in fat cells, and likely contributes to PRL-induced insulin resistance.
- AOX, acyl Co-A oxidase
- DMEM, Dulbecco's modified Eagle's medium
- EMSA, electrophoretic mobility shift assay
- ERK, extracellular signal–related kinase
- FAS, fatty acid synthase
- FBS, fetal bovine serum
- GH, growth hormone
- MAPK, mitogen-activated protein kinase
- PDC, pyruvate dehydrogenase complex
- PDK, pyruvate dehydrogenase kinase
- PGC, peroxisome proliferator–activated γ coactivator
- PRL, prolactin
- SOCS, suppressors of cytokine signaling
Footnotes
-
Published ahead of print at http://diabetes.diabetesjournals.org on 14 March 2007. DOI: 10.2337/db06-1286.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted February 19, 2007.
- Received September 12, 2006.
- DIABETES











